Showing results (151-160 of 306) with videos related to
Sort By:
Pageof 31
Plos One|June 24, 2016
Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from MiceSteffen K Meurer, Melanie Neß, Sabine Weiskirchen, et al.Mbio|September 11, 2020
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2Idoia Busnadiego, Sonja Fernbach, Marie O Pohl, et al.Anticancer Research|December 25, 2009
Tumour Biology: tumour-associated inflammation versus antitumor immunityBoris Müller-Hübenthal, Marc Azemar, Dirk Lorenzen, et al.Antimicrobial Resistance and Infection Control|March 22, 2021
Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test centerThomas Scheier, Cyril Shah, Michael Huber, et al.Cellular Signalling|January 26, 2011
Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cellsThomas Hochdörfer, Marcel Kuhny, Carolin N Zorn, et al.International Journal of Molecular Medicine|January 14, 2004
Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cellsAndreas Renkl, Luciana Berod, Maja Mockenhaupt, et al.JTO Clinical and Research Reports|November 12, 2021
Severe Psychiatric Symptoms in a Patient With <i>EGFR</i> Exon-20 Insertion Mutation Receiving Mobocertinib: A Case ReportJosette Kamel, Natalie Meeder, Sandra Cuellar, et al.Plos One|November 4, 2014
High-throughput sequencing of human immunoglobulin variable regions with subtype identificationMerle Schanz, Thomas Liechti, Osvaldo Zagordi, et al.BMC Infectious Diseases|July 10, 2019
Meningitis and epididymitis caused by Toscana virus infection imported to Switzerland diagnosed by metagenomic sequencing: a case reportFabian Tschumi, Stefan Schmutz, Verena Kufner, et al.Oncotarget|February 10, 2018
Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemiaThomas Wilhelm, Fabian Bick, Kerstin Peters, et al.Pageof 31